FDA Approves New Drug That Could Slow Breast Cancer Progression
My AccountFIND A DOCTORNewsCelebrityNew LaunchesTreatment & FDA NewsIndustry & Retail NewsFaceAcneAnti-AgingCelebrityEye CareHyperpigmentationMakeupSensitive SkinSkin CareSkin ConditionsSmileSun CareTreatmentsNeurotoxinsFillersLasers & Energy DevicesMicroneedlingPost-Procedure Skin CareAnti-WrinkleRegenerative AestheticsBodySkin CareBody SculptingBreastsButtsCelluliteFragranceHands + NailsLegsPregnancyHairBond RepairCelebrity HairDry HairFrizzy HairGray HairHair ColorHair GrowthHair RepairScalp HealthTips + TutorialsAwardsNB100 Awards16th Annual Beauty Awards2025 NewBeauty Readers’ Choice AwardsShoppingBeautyReportGift GuidesNewBeauty StorefrontProduct ReviewsWellnessFitnessGLP-1sHealthMenopauseTESTTUBENewsView All NewsCelebrityNew LaunchesTreatment & FDA NewsIndustry & Retail NewsFaceView All FaceAcneAnti-AgingCelebrityEye CareHyperpigmentationMakeupSensitive SkinSkin CareSkin ConditionsSmileSun CareTreatmentsView All TreatmentsNeurotoxinsFillersLasers & Energy DevicesMicroneedlingPost-Procedure Skin CareAnti-WrinkleRegenerative AestheticsBodyView All BodySkin CareBody SculptingBreastsButtsCelluliteFragranceHands + NailsLegsPregnancyHairView All HairBond RepairCelebrity HairDry HairFrizzy HairGray HairHair ColorHair GrowthHair RepairScalp HealthTips + TutorialsAwardsView All AwardsNB100 Awards16th Annual Beauty Awards2025 NewBeauty Readers’ Choice AwardsShoppingView All ShoppingBeautyReportGift GuidesNewBeauty StorefrontProduct ReviewsWellnessView All WellnessFitnessGLP-1sHealthMenopauseLoading…FIND A DOCTORTESTTUBE Advertisement Home›Breasts FDA Approves New Drug That Could Slow Breast Cancer Progression A breakthrough for advanced breast cancer. Tatiana BidoInstagramAbout NewBeauty Jul 20, 2026 Photo by Kateryna Hliznitsova on Unsplash The U.S. Food and Drug Administration (FDA) has approved new targeted therapy for certain patients with advanced breast cancer whose disease has progressed despite hormone therapy. The approval gives breast cancer patients another option for one of the most common forms of advanced breast cancer. The treatment, called REVTORPYK (gedatolisib), from Celulicity, is approved for adults with hormone receptor (HR)-positive, HER2-negative locally advanced or metastatic breast cancer whose tumors do not have a PIK3CA mutation. While those terms may sound technical, this subtype accounts for the majority of breast cancer diagnoses, and many patients eventually need additional treatment when hormone therapy is no longer effective.